Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Cost-Effectiveness Analysis of...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

Bibliographic Details
Main Authors: Diego Centonze, Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Luigi Giuliani, Pier Luigi Canonico
Format: Article
Language:English
Published: SEEd Medical Publishers 2018-11-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
cost-effectiveness
peginterferon beta-1a
multiple sclerosis
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1385
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1385

Similar Items

  • [Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy]
    by: Sergio Iannazzo, et al.
    Published: (2016-07-01)
  • [Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management]
    by: Sergio Iannazzo, et al.
    Published: (2016-07-01)
  • An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists
    by: Annette Kolb-Mäurer, et al.
    Published: (2019-06-01)
  • [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]
    by: Gianluca Furneri, et al.
    Published: (2016-06-01)
  • Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
    by: Young Kul Jung, et al.
    Published: (2013-03-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...